Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | 10 pathways; mostly immune signalling | 0.90 |
No case: the score is under the bar. Receipt 11087
Sealed predictions
- GNAI2 in dopamine neurons, braak-0.37 (p 0.329) → -0.56 (p 0.118)receipt 11093
Swarm cases
receipt 11093: GNAI2 in dopamine neurons, braak
- power
- full sample -0.52 (p 0.026, n 18), 95% CI -0.80 to -0.07. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.52 (p 0.027, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.60 (p 0.0086, n 18). not the mix.
- skeptic
- leave-one-out range -0.64 to -0.46, sign flips 0; without severely affected donors -0.52 (p 0.026, n 18). robust.
- cell type
- strongest in OPCs: -0.60 (p 0.0080, n 18) vs -0.52 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for GNAI2 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up GNAI2 · OPCs · braak: substantia nigra, an independent cohort: not measured
Receipts
loading the receipts